UMIN ID: UMIN000005096
Registered date:01/03/2011
11C-methionine PET for diagnoses of lung cancer and lymph node metastases in the mediastinum and pulmonary hilum: probability of prognostic prediction
Basic Information
Recruitment status | Complete: follow-up complete |
---|---|
Health condition(s) or Problem(s) studied | lung cancer |
Date of first enrollment | 2009/04/01 |
Target sample size | 40 |
Countries of recruitment | Japan |
Study type | Interventional |
Intervention(s) | To scan PET-CT after administering intravenously 11C-methionine in patients with lung cancer. |
Outcome(s)
Primary Outcome | The assessment of our study is to calculate SUVmax of primary lesion and lymph node metastasis on 11C-MET-PET, correlating with morphological evaluation using CT and histopathological evaluation. |
---|---|
Secondary Outcome |
Key inclusion & exclusion criteria
Age minimum | 20years-old |
---|---|
Age maximum | Not applicable |
Gender | Male and Female |
Include criteria | |
Exclude criteria | not getting informed consent from patients |
Related Information
Primary Sponsor | The department of nuclear medicine in osaka university graduate school of medicine |
---|---|
Secondary Sponsor | |
Source(s) of Monetary Support | global COE program |
Secondary ID(s) |
Contact
public contact | |
Name | Jun Hatazawa |
Address | 2-2, Yamadaoka, Suita, Japan Japan |
Telephone | 06-6879-3461 |
hatazawa@tracer.med.osaka-u.ac.jp | |
Affiliation | Osaka university graduate school of medicine Nuclear medicine |
scientific contact | |
Name | Jun Hatazawa |
Address | 2-2, Yamadaoka, Suita, Japan Japan |
Telephone | 06-6879-3461 |
hatazawa@tracer.med.osaka-u.ac.jp | |
Affiliation | Osaka university graduate school of medicine Nuclear medicine |